MASIMO CORP
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?
The life sciences giant is transforming its diagnostics segment with its acquisition of Masimo Corporation, shifting from traditional laboratory testing into patient-connected, real-time data streams.
Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo
The wearables in pharma & biotech market is forecasted to grow from USD 3.98 billion in 2026 to USD 9.97 billion by 2031, at a CAGR of 20.2%. This rapid growth is fueled by advances in biosensor technology, miniaturization, and digitization, supported by strong internet connectivity worldwide. Programs like "All of Us" and RPM adoption are boosting wearables' role in research and healthcare. CGMs lead product segments due to robust clinical backing, while pharma and biotech companies were top en
Congressional Trades in $MASI
View full $MASI trading history →Insider Trades (Form 4)
No Form 4 insider trades found for $MASI.
Key People
No individuals linked to this entity yet.
Political Giving
$1,000 given to 1 candidate across 1 disclosed contribution (FEC Schedule A).
Gus M. Bilirakis
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro